Abstract:Objective Using genome-wide promoter methylation assay, B cell CLL/lymphoma 6 member B (BCL6B) was found to be preferentially methylated in cancer. A study was undertaken to examine the epigenetic regulation, biological function and clinical significance of BCL6B in gastric cancer (GC).Methods BCL6B promoter methylation was evaluated by combined bisulfite restriction analysis and sequencing. The biological functions of BCL6B were determined by cell viability, colony formation, flow cytometry and in vivo tumorigenicity assays. The molecular targets of BCL6B were identified by cDNA expression array.Results BCL6B was silenced or downregulated in all nine GC cell lines and readily expressed in normal gastric tissues. Loss of BCL6B expression was regulated by promoter hypermethylation. Re-expression of BCL6B in GC cell lines inhibited colony formation, suppressed cell viability, induced apoptosis and restrained the tumorigenecity in nude mice. These effects were associated with upregulation of the pro-apoptosis genes tumour necrosis factor receptor superfamily member 1A, caspase-8, caspase-9, caspase-3 and caspase-7 and nuclear enzyme poly (ADP-ribose) polymerase, downregulation of the pro-proliferation genes S100 calcium binding protein A4 and vascular endothelial growth factor A, and induction of the tumour suppressor genes ataxia telangiectasia mutated homologue and p53. BCL6B hypermethylation was detected in 49.0% (102/208) and 66.3% (67/101) of two independent cohorts of patients with GC, respectively. BCL6B methylation was an independent factor for the survival of patients with GC (p=0.001 for cohort I, p=0.02 for cohort II).Conclusions BCL6B plays a pivotal role as a potential tumour suppressor in GC. Detection of methylated BCL6B may serve as an independent biomarker for the prognosis of GC.

Nucleophosmin/B23 Negatively Regulates GCN5-dependent Histone Acetylation and Transactivation

Nucleophosmin/B23 Inhibits Eg5-mediated Microtubule Depolymerization by Inactivating Its ATPase Activity

Sumoylation Of Nucleophosmin/B23 Regulates Its Subcellular Localization, Mediating Cell Proliferation And Survival

Distinct Roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in Nuclear Receptor Transactivation.

Upregulation of B23 promotes tumor cell proliferation and predicts poor prognosis in glioma.

Eb1 Acetylation By P300/Cbp-Associated Factor (Pcaf) Ensures Accurate Kinetochore-Microtubule Interactions In Mitosis

Aberrant DNA Methylation Associated with Silencing BNIP3 Gene Expression in Haematopoietic Tumours

Nucleophosmin/B23 is a proliferate shuttle protein associated with nuclear matrix

B23 Acts As a Nucleolar Stress Sensor and Promotes Cell Survival Through Its Dynamic Interaction with Hnrnpu and Hnrnpa1

Nucleophosmin/B23 interacts with p21WAF1/CIP1 and contributes to its stability.

B23 Regulates GADD45a Nuclear Translocation and Contributes to GADD45a-induced Cell Cycle G2-M Arrest

[High Expression of Nucleophosmin/b23 in Hepatocellular Carcinoma].

Epigenetic Inactivation of Bcl6b, A Novel Functional Tumour Suppressor for Gastric Cancer, is Associated with Poor Survival

Nucleolar protein B23 has molecular chaperone activities

Histone Acetyltransferase P 300 / CBP Inhibitor C 646 Blocks the Survival and Invasion Pathways of Gastric Cancer Cell Lines

Inhibitor of CBP Histone Acetyltransferase Downregulates p53 Activation and Facilitates Methylation at Lysine 27 on Histone H3

DNA Methyltransferase 1 and 3B Activate BAG-1 Expression Via Recruitment of CTCFL/BORIS and Modulation of Promoter Histone Methylation.

Identification Of Novel Alpha-N-Methylation Of Cenp-B That Regulates Its Binding To The Centromeric Dna

LINC00355 Promotes Gastric Carcinogenesis by Scaffolding P300 to Activate CDC42 Transcription and Enhancing HNRNPA2B1 to Stabilize CDC42 Mrna Dependent on M6a.

Inhibition of nucleophosmin/B23 sensitizes ovarian cancer cells to immune check-point blockade via PD-L1 in ovarian cancer

The Role of Nucleophosmin/b23 in Radiation-Induced Chromosomal Instability in Human Lymphoblastoid Cells of Different P53 Genotypes